Items Tagged with 'Pharmaceutical'

Genentech’s $2-billion North Carolina biomanufacturing expansion mid-build tests how power, water and labor constraints are shaping advanced manufacturing construction.

Rising tariffs and regulatory shake-ups are reshaping how drugmakers plan, design and deliver the next generation of U.S. biomanufacturing facilities.

Manufacturing project in North Carolina features buildings, layouts and systems designed to be easily duplicated.

The first phase of Fujifilm Biotechnologies’ $3.2-billion large-scale cell culture biopharmaceutical manufacturing plant in North Carolina is scheduled to begin operating this year.

Danish pharmaceutical company Novo Nordisk recently announced plans to spend approximately $1.2 billion to build a new production facility in Odense, Denmark.

Novo Nordisk, the Denmark-based health care company, is planning to invest $4.1 billion to expand its U.S. manufacturing capacity with a second fill and finishing facility in Clayton, N.C.

Agilent Technologies plans to open the new oligonucleotide manufacturing lines in 2026.

Moving COVID-19 remedies through development, testing, production and global distribution has pharmaceutical and R&D firms and their industry designers and builders rushing to maximize space and productivity.